← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lipella Pharmaceuticals, Inc.
Pittsburgh, PA
$8,961,884
Total funding
11
Grants
Funding over time
peak $1.3M · FY2006–23$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,961,884 · 11
By mechanism
R44$4,599,850 · 4
R42$2,728,394 · 2
SB1$998,466 · 1
R43$410,175 · 3
R41$224,999 · 1
Investigators at Lipella Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay$680,049
R44 · FY2023 · DK
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay$673,049
R44 · FY2022 · DK
Measuring Bladder Permeability with MRI Using a Novel Contrast Agent Formulation$656,417
R42 · FY2018 · DK
Preclinical Development of Tacrolimus for Radiation Cystitis$648,461
R44 · FY2015 · DK
Preclinical Development of Tacrolimus for Radiation Cystitis$629,914
R44 · FY2016 · DK
Measuring Bladder Permeability with MRI Using a Novel Contrast Agent Formulation$585,001
R42 · FY2019 · DK
Clinical Development of Tacrolimus for Hemorrhagic Cystitis$514,245
SB1 · FY2017 · DK
Bladder drug delivery using intravesical liposomes to treat overactive bladder$498,910
R44 · FY2012 · DK
Bladder drug delivery using intravesical liposomes to treat overactive bladder$497,291
R44 · FY2011 · DK
Clinical Development of Tacrolimus for Hemorrhagic Cystitis$484,221
SB1 · FY2018 · DK
Intravesical Liposome Treatment for Interstitial Cystitis$375,000
R44 · FY2009 · DK
Intravesical Liposome Treatment for Interstitial Cystitis$375,000
R44 · FY2008 · DK
Developing Intravesical Liposomes for Interstitial Cystitis$373,022
R42 · FY2015 · DK
Developing Intravesical Liposomes for Interstitial Cystitis$368,266
R42 · FY2014 · DK
Developing Intravesical Liposomes for Interstitial Cystitis$344,608
R42 · FY2010 · DK
Developing Intravesical Liposomes for Interstitial Cystitis$239,516
R42 · FY2011 · DK
Measuring Bladder Permeability with MRI using a Novel Contrast Agent Formulation$224,999
R41 · FY2015 · DK
Preclinical Development of Tacrolimus for Radiation Cystitis$222,176
R44 · FY2014 · DK
Rapid Point-of-Care Diagnostic Kit for Mosquito Borne Diseases in Urine$210,558
R43 · FY2017 · AI
Developing Intravesical Liposomes for Interstitial Cystitis$156,564
R42 · FY2009 · DK